The ESC Handbook on Cardiovascular Pharmacotherapy, based on the most recent guidelines in cardiovascular pharmacology, and containing a comprehensive A-Z formulary of common and less commonly used cardiac drugs and drug groups, provides practical and accessible guidance on all areas of drug prescribing.

This European Society of Cardiology (ESC) Handbook on Cardiovascular Pharmacotherapy has been developed by experts from the ESC Working Group on Cardiovascular Pharmacotherapy. Its recommendations are aligned with the ESC Clinical Practice Guidelines and based on the most recent scientific evidence in cardiovascular pharmacology and pharmacotherapy. The Handbook provides up-to-date information on pharmacotherapy for cardiovascular disease prevention, and treatment of cardiovascular disease, including ischaemic heart disease, heart failure, arrhythmias, and structural heart disease. The Handbook also deals with the important problems of cardiovascular pharmacotherapy in pregnancy and lactation, kidney insufficiency, and liver disease as well as focusing on major drug interactions, a topic of extreme importance in clinical practice. Two large sections of the book provide a comprehensive A-Z formulary of cardiac and non-cardiac pharmacological agents with practical and accessible information on the most important pharmacological aspects of these agents and their use in clinical practice.

The Handbook represents essential reading for cardiologists, general practitioners, internal medicine specialists, anaesthetists, clinical pharmacologists, geriatricians, obstetricians, and cardiovascular nurse consultants. Junior doctors and trainees in all these specialties are also likely to find this book of help.

The print edition comes with full access to the online version that will be updated at yearly intervals to keep it up to date.

Autorentext
Professor Kaski is the Immediate Past Director of the Cardiovascular and Cell Sciences Research Institute, St George's, University of London. He is Doctor of Science, University of London, Fellow of the Royal College of physicians (London), the European Society of Cardiology, the American College of Cardiology and the American Heart Association, among over 20 other scientific societies worldwide. He is Deputy Editor in Chief, International Journal of Cardiology, Editor in Chief, European Cardiology Review and the Cardiovascular Pharmacotherapy book series, ISCP. Professor Kjeldsen is author of over 200 papers and multiple books. Presenter of over 100 lectures nationally and internationally, he is Chairman at 45 scientific sessions. He has extensive experience as peer reviewer at scientific journals, from editorial boards, as chairman and organizer of meetings and congresses and as examiner of theses and research projects nationally and internationally. Teaching interests include Cardiology, cardiovascular pharmacology, and research methodology.

Inhalt

• Section 1: Cardiovascular Disease Prevention

• 1: Robert Zweiker and Sabine Perl: Hypertension

• 2: Heinz Drexel: Dyslipidaemia

• 3: Christoph Säly: Metabolic Syndrome and Diabetes

• 4: Freek Verheugt: Thrombosis

• Section 2: Ischaemic Heart Disease

• 1: Abhiram Prasad and Claire Raphael: Acute Coronary Syndromes

• 2: Gaetano Antonio Lanza and Antonio De Vita: Chronic stable angina

• 3: Peter Ong and Udo Sechtem: Coronary artery spasm and microvascular angina

• 4: Alexander Lyon, Mark Sweeney, and Elmir Omerovic: Takotsubo Syndrome

• Section 3: Heart Failure

• 1: Faiez Zannad, Joao Pedro Ferreira, and Theresa McDonagh: Heart failure

• 2: Finn Gustafsson and Kasper Rossing: Heart transplantation

• Section 4: Arrhythmias

• 1: George Dan and Jan Steffel: Atrial fibrillation

• 2: Julio Martí: Supraventricular (narrow complex) tachycardias

• 3: Martin Borggrefe, Erol Tülümen, and Josep Brugada: Ventricular arrhythmias

• 4: Haran Burri: Bradyarrhythmias

• 5: Ricardo Ruiz-Granell: Syncope

• Section 5: Structural heart disease

• 1: Francesca Mantovani: Valvular Heart Disease

• 2: Giovanni Boffa and Claudio Ceconi: Myocarditis/ Pericardial Syndromes

• 3: Giovanni Boffa: Cardiomyopathy

• 4: James Tonkin, Kate Ryan and Brendan Madden: Pulmonary Hypertension

• Section 6: Management of cardiovascular disease in pregnancy and lactation and in the presence of co-morbidities

• 1: Debasish Banerjee, Robin Ramphul, and David Goldsmith: Kidney disease

• 2: Anita Banerjee, Debasish Banerjee, and Vivek Jha: Pregnancy and lactation

• 3: Nina Hojs, Aftab Ala, and Debasish Banerjee: Liver disease

• Section 7: Major drug interactions

• 1: Maja Hellfritzsch Poulsen and Marlene Lunddal Krogh: Major drug interactions

• Section 8: Cardiovascular drugs from A to Z

• 1: Juan Tamargo, Ricardo Caballero and Eva Delpón: Cardiovascular drugs from A to Z

• Section 9: Non-cardiac drugs affecting the heart - from A to Z

• 1: Eva Delpón and Juan Tamargo: Non-cardiac drugs affecting the heart